Olympus Corporation

NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System

Retrieved on: 
Mittwoch, März 27, 2024
Cloud, Internet, QKD, Google Images, Safety, ICT, Software, Nippon Telegraph and Telephone, PQC, Computer, Collection, Communication, NTT, NBI, Cloud computing, Observation, Environment, Human, Physician, Endoscopy, Olympus Corporation, Digital twin, GPU, Graphics processing unit, APN, Post-quantum cryptography, Knowledge, Computer data storage

Cloud endoscopy system using NTT's high-speed, low-latency IOWN APN technology

Key Points: 
  • Cloud endoscopy system using NTT's high-speed, low-latency IOWN APN technology
    TOKYO, Mar 27, 2024 - (JCN Newswire) - NTT Corporation (NTT) and Olympus Corporation (Olympus) today announce that the two companies have jointly begun a demonstration experiment of a cloud endoscopy system that enables image processing on the cloud.
  • To realize a cloud endoscopy system, NTT and Olympus have started demonstration experiments centered on IOWN APN to solve technical problems in the network.
  • Based on the knowledge gained from the demonstration experiment, NTT and Olympus will jointly consider the commercialization of the cloud endoscopy system.
  • In this demonstration experiment, Olympus will provide the specific requirements and evaluation items for the cloud endoscopy concept, as well as the endoscopic equipment for the demonstration experiment.

Electrosurgery Market to be Worth $8.99 Billion by 2031 - Exclusive Report by Meticulous Research®

Retrieved on: 
Mittwoch, Mai 8, 2024
Smoke, United Nations, Risk, General surgery, Surgeon, Electrosurgery, Medtronic, Smith, Olympus Corporation, Boston Scientific, Lip, Perforation, Prevalence, Skin, Medical tourism, Spine, Obstetrics, Ageing, Argon, Plasma, Conditional sentence, Hospital, Generator, Geography, ENT, Johnson & Johnson, Bleeding, Incidence, Government, BPH, Stryker Corporation, Steris, ASC, Disease, United, Patient, Coagulation, Circulatory system, Cancer, Growth, Dentistry

Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.

Key Points: 
  • Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.
  • However, the risks associated with electrosurgical procedures and the shortage of surgeons restrain the growth of this market.
  • The report also includes an extensive assessment of the key growth strategies adopted by leading market players over the past three years.
  • The global electrosurgery market has witnessed several product launches, product approvals, acquisitions, and expansions in the last couple of years.

Electrosurgery Market to be Worth $8.99 Billion by 2031 - Exclusive Report by Meticulous Research®

Retrieved on: 
Mittwoch, Mai 8, 2024
Smoke, United Nations, Risk, General surgery, Surgeon, Electrosurgery, Medtronic, Smith, Olympus Corporation, Boston Scientific, Lip, Perforation, Prevalence, Skin, Medical tourism, Spine, Obstetrics, Ageing, Argon, Plasma, Conditional sentence, Hospital, Generator, Geography, ENT, Johnson & Johnson, Bleeding, Incidence, Government, BPH, Stryker Corporation, Steris, ASC, Disease, United, Patient, Coagulation, Circulatory system, Cancer, Growth, Dentistry

Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.

Key Points: 
  • Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.
  • However, the risks associated with electrosurgical procedures and the shortage of surgeons restrain the growth of this market.
  • The report also includes an extensive assessment of the key growth strategies adopted by leading market players over the past three years.
  • The global electrosurgery market has witnessed several product launches, product approvals, acquisitions, and expansions in the last couple of years.

HR Technology Conference & Exposition® Europe Announces Additional Agenda Details

Retrieved on: 
Montag, März 18, 2024
UX, HR, Organization, Conference, Noise, Corporate sustainability, Digital, Expert, Business, General partnership, PALM, Research, Transformation, Organizational culture, Olympus Corporation, Senior, RAI Amsterdam, Avalere Health, Stanford University, ETC, Workplace, Tech, Management

WEST PALM BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- The upcoming HR Technology Conference & Exposition® Europe today shared additional agenda details in the lead-up to the two-day event taking place at the RAI Amsterdam, May 2 – 3, 2024.

Key Points: 
  • WEST PALM BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- The upcoming HR Technology Conference & Exposition® Europe today shared additional agenda details in the lead-up to the two-day event taking place at the RAI Amsterdam, May 2 – 3, 2024.
  • Beyond the previously announced keynote sessions , the HR Technology Conference Europe will feature a full slate of Tech Talks, Ask the Experts and much more.
  • Rebecca McKenna, Senior Vice President, HR Portfolio at ETC, shared, “The HR Technology Conference Europe promises to be an exceptional event that looks at the issues impacting today’s HR teams from multiple vantage points.
  • Attendees will have the opportunity to hear from industry analysts, practitioners and solution providers, all focused on advancing the HR discipline and improving the very nature of work.”
    The agenda for the HR Technology Conference & Exposition® Europe is updated on a regular basis.

Olympus Corporation of the Americas' Julien Sauvagnargues Steps into CEO Role

Retrieved on: 
Mittwoch, März 27, 2024
Grifols, Nachos, Olympus Corporation, AdvaMed, OCA, CSO, Medtech, Corporation, Management

CENTER VALLEY, Pa., March 27, 2024 /PRNewswire/ -- Olympus, a leading global MedTech company providing innovative solutions for medical and surgical procedures, announced today the appointment of Julien Sauvagnargues to the role of President and Chief Executive Officer (CEO), Olympus Corporation of the Americas (OCA), reporting to Olympus Chief Strategy Officer (CSO), Gabriela Kaynor, effective April 1, 2024.

Key Points: 
  • This new step in Mr. Sauvagnargues' career at Olympus, which began in 2006, builds upon his tenure as OCA President since 2020.
  • Mr. Glavin came to Olympus in 2016 in a consultant role and became the OCA Chief Compliance Officer that same year.
  • These leadership changes are in part due to the departure from Olympus of Nacho Abia, former OCA CEO and global CSO.
  • "We cannot be grateful enough for Nacho's 23-year tenure with this company," said Stefan Kaufmann, CEO, Olympus Corporation.

Olympus Partners with American Lung Association on Patient Education for Lung Cancer Screening

Retrieved on: 
Mittwoch, März 27, 2024
Diagnosis, Biopsy, Lung cancer, Medicine, Immunotherapy, Disease, Infection, Partnership, Patient, Sore throat, Perforation, Cancer, United, Olympus Corporation, Senior, Lymph, Bleeding, EUS, American Lung Association, Physician, Medical imaging

CENTER VALLEY, Pa., March 27, 2024 /PRNewswire/ -- Olympus Corporation of the Americas, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, is now partnering with the American Lung Association to educate lung cancer patients about the care pathway for diagnosing and staging lung nodules.

Key Points: 
  • The lung nodules educational resources , sponsored by Olympus, help patients understand the diagnosis and staging process for lung nodules and why it is important to their treatment journey.
  • "Olympus is very excited to support this great new educational resource for lung cancer patients through our partnership with the American Lung Association," said Jovan Reyerson, Senior Vice President of Medical and Scientific Affairs at Olympus Corporation of the Americas.
  • Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), a procedure pioneered by Olympus, has helped lay the groundwork for targeted cancer treatment such as immunotherapy.
  • Lung cancer remains the leading cause of cancer death in the United States.² Early detection of lung cancer is key as the 5-year relative survival rate for non-small cell lung cancer is about 65% when caught at a localized stage.

Near Infrared Imaging Market Projected to Reach $3.60 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Montag, März 18, 2024
Retina, Device, Algorithm, Health, MRI, Growth, Cardiology, Science, Agriculture, Intelligence, Risk, Single-camera setup, Tissue, Cancer, Research, KARL, Ischemia, Overalls, Ophthalmology, Olympus Corporation, Gastrointestinal tract, NIRI, Shimadzu, Investment, Patient safety, Obstruction, Table, Perfusion, Infrared, Carl Zeiss AG, Medicine, Medical imaging

Near Infrared Imaging (NIRI) is transforming the landscape of non-invasive diagnostics with its capability to utilize wavelengths between 700 and 2500 nanometers, providing deep insights into biological tissues.

Key Points: 
  • Near Infrared Imaging (NIRI) is transforming the landscape of non-invasive diagnostics with its capability to utilize wavelengths between 700 and 2500 nanometers, providing deep insights into biological tissues.
  • The key players in the Near Infrared Imaging Market include Hamamatsu Photonics K.K., KARL STORZ SE & Co. KG, Olympus Corporation, Carl Zeiss AG, Shimadzu Corporation, and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Near Infrared Imaging Market.
  • "Dive into the Near Infrared Imaging Market Landscape: Explore 186 Pages of Insights, 558 Tables, and 22 Figures"

Near Infrared Imaging Market Projected to Reach $3.60 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Montag, März 18, 2024
Retina, Device, Algorithm, Health, MRI, Growth, Cardiology, Science, Agriculture, Intelligence, Risk, Single-camera setup, Tissue, Cancer, Research, KARL, Ischemia, Overalls, Ophthalmology, Olympus Corporation, Gastrointestinal tract, NIRI, Shimadzu, Investment, Patient safety, Obstruction, Table, Perfusion, Infrared, Carl Zeiss AG, Medicine, Medical imaging

Near Infrared Imaging (NIRI) is transforming the landscape of non-invasive diagnostics with its capability to utilize wavelengths between 700 and 2500 nanometers, providing deep insights into biological tissues.

Key Points: 
  • Near Infrared Imaging (NIRI) is transforming the landscape of non-invasive diagnostics with its capability to utilize wavelengths between 700 and 2500 nanometers, providing deep insights into biological tissues.
  • The key players in the Near Infrared Imaging Market include Hamamatsu Photonics K.K., KARL STORZ SE & Co. KG, Olympus Corporation, Carl Zeiss AG, Shimadzu Corporation, and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Near Infrared Imaging Market.
  • "Dive into the Near Infrared Imaging Market Landscape: Explore 186 Pages of Insights, 558 Tables, and 22 Figures"

Otolith Labs Expands Leadership Team with the Appointment of Dan Wagner as its Chief Commercial Officer and Raphael Michel to its Board of Directors

Retrieved on: 
Mittwoch, Februar 21, 2024
Biotechnology, Medical Devices, Other Health, Health, Health Technology, Therapy, Boston Scientific, Eargo, Marketing, Hansen Medical, CCO, Olympus Corporation, Stanford University, IPO, Vertigo, Otolith, Johnson & Johnson, Patient, DSM-IV codes, DME, University of California, Berkeley, Pharmaceutical industry

Otolith Labs, a medical technology company developing non-invasive wearable medical devices for the treatment of vestibular disorders, appointed Dan Wagner as Chief Commercial Officer (CCO) and Raphael Michel as an independent Board member.

Key Points: 
  • Otolith Labs, a medical technology company developing non-invasive wearable medical devices for the treatment of vestibular disorders, appointed Dan Wagner as Chief Commercial Officer (CCO) and Raphael Michel as an independent Board member.
  • Otolith Labs’ technology is a head-worn wearable device being investigated for the treatment of vertigo episode symptoms associated with vestibular migraines.
  • “Dan has been working with Otolith in an advisory role for over 5 years, so we are thrilled to have him full-time.
  • “Raphael is one of our earliest industry advisors and has been providing critical counsel to Otolith Labs since 2016.

NDT and Inspection Market worth $18.4 billion by 2029- Exclusive Report by MarketsandMarkets™

Retrieved on: 
Donnerstag, Februar 15, 2024
Cygnus, Bureau Veritas, CT scan, Region, Growth, Ultrasound, Health, Fatigue, SGS, VPAC, Olympus Corporation, RBI, Structure, Intertek, TED, Aluminium, Plant, TIC, Comet Group, Nondestructive testing, Steel, Carestream Health, Statistics, Digital imaging, Smart city, Computed radiography, Natural Resources, Aircraft, AET, Safety, Acoustic emission, Power, Automation, Acquisition, 2D, Medicine, AI, Internet of things, Power plant engineering, Government, General Electric, Make, FDI, Communication, NDT, Geography, Industrial, Measurement, Wind, Inspection

The power Generation vertical of the NDT and Inspection market is predicted to register the highest market share between 2024-2029.

Key Points: 
  • The power Generation vertical of the NDT and Inspection market is predicted to register the highest market share between 2024-2029.
  • NDT and Inspection market for the Asia Pacific region to register the highest CAGR between 2024 and 2029 forecast.
  • The Asia Pacific region is poised to emerge as the fastest-growing market for NDT and inspection, driven by rapid infrastructural developments.
  • However, challenges such as pricing pressures pose a limitation to the growth of the NDT and inspection industry in Asia Pacific.